The only thing “building” is the OS count. It’s overvalued as it sits now In respect to financials. That will not change . If Q2 results in August, even with all the pumping of new products , show meager improvement in revenue but continuing expense costs even you will have to admit this company is not a winner and it will be time to throw in the towel. Trade this stock like the otc company it really is.
News 
Market Data 
Discover 
